Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease: National cohort study

Chieh Li Yen; Chao Yi Wu; Lai Chu See; Yi Jung Li; Min Hua Tseng; Wei Sheng Peng; Jia Rou Liu; Yung Chang Chen; Tzung Hai Yen; Ya Chung Tian; Chih Wei Yang; Gerard F. Anderson; Huang Yu Yang

doi:10.2337/dc20-1584

Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease: National cohort study

Chieh Li Yen, Chao Yi Wu, Lai Chu See, Yi Jung Li, Min Hua Tseng, Wei Sheng Peng, Jia Rou Liu, Yung Chang Chen, Tzung Hai Yen, Ya Chung Tian, Chih Wei Yang, Gerard F. Anderson, Huang Yu Yang^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal Letter › peer-review

11 Scopus citations

Original language	English
Pages (from-to)	e152-e153
Journal	Diabetes Care
Volume	43
Issue number	10
DOIs	https://doi.org/10.2337/dc20-1584
State	Published - 10 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc20-1584

Cite this

Yen, C. L., Wu, C. Y., See, L. C., Li, Y. J., Tseng, M. H., Peng, W. S., Liu, J. R., Chen, Y. C., Yen, T. H., Tian, Y. C., Yang, C. W., Anderson, G. F., & Yang, H. Y. (2020). Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease: National cohort study. Diabetes Care, 43(10), e152-e153. https://doi.org/10.2337/dc20-1584

@article{410b85e81f184460bb11beaf4694f373,

title = "Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease: National cohort study",

author = "Yen, {Chieh Li} and Wu, {Chao Yi} and See, {Lai Chu} and Li, {Yi Jung} and Tseng, {Min Hua} and Peng, {Wei Sheng} and Liu, {Jia Rou} and Chen, {Yung Chang} and Yen, {Tzung Hai} and Tian, {Ya Chung} and Yang, {Chih Wei} and Anderson, {Gerard F.} and Yang, {Huang Yu}",

year = "2020",

month = oct,

doi = "10.2337/dc20-1584",

language = "英语",

volume = "43",

pages = "e152--e153",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "10",

}

TY - JOUR

T1 - Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease

T2 - National cohort study

AU - Yen, Chieh Li

AU - Wu, Chao Yi

AU - See, Lai Chu

AU - Li, Yi Jung

AU - Tseng, Min Hua

AU - Peng, Wei Sheng

AU - Liu, Jia Rou

AU - Chen, Yung Chang

AU - Yen, Tzung Hai

AU - Tian, Ya Chung

AU - Yang, Chih Wei

AU - Anderson, Gerard F.

AU - Yang, Huang Yu

PY - 2020/10

Y1 - 2020/10

UR - http://www.scopus.com/inward/record.url?scp=85091470275&partnerID=8YFLogxK

U2 - 10.2337/dc20-1584

DO - 10.2337/dc20-1584

M3 - 快报

C2 - 32801131

AN - SCOPUS:85091470275

SN - 0149-5992

VL - 43

SP - e152-e153

JO - Diabetes Care

JF - Diabetes Care

IS - 10

ER -

Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease: National cohort study

UN SDGs

Access to Document

Other files and links

Cite this